Open AccessTreatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
Author(s) -
Francesco Oddone,
Vincenzo Scorcia,
Michele Iester,
Dario Sisto,
Stefano De Cillà,
Paolo Bettin,
Carlo Cagini,
Michele Figus,
Giorgio Marchini,
Luca Rossetti,
Gemma Caterina Maria Rossi,
Tommaso Salgarello,
Gian Luca Scuderi,
Giovanni Staurenghi
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s364880
Subject(s) - medicine , timolol , ophthalmology , ocular hypertension , glaucoma , open angle glaucoma
The VISIONARY study examined the intraocular pressure (IOP)-lowering efficacy and tolerability of the preservative-free fixed-dose combination of tafluprost (0.0015%) and timolol (0.5%) (PF tafluprost/timolol FC) in a real-world setting. The country-level data reported herein comprise the largest and first observational study of PF tafluprost/timolol FC therapy in Italy.